
The revision maintains insurance coverage for all vaccines but moves several doses into high-risk or shared decision-making categories as HHS commits to new clinical trials.
Austin Littrell is assistant editor of Medical Economics.

The revision maintains insurance coverage for all vaccines but moves several doses into high-risk or shared decision-making categories as HHS commits to new clinical trials.